-
Loading metrics
Immunogenicity and safety of a recombinant adenovirus type-5 COVID-19 vaccine in adults: Data from a randomised, double-blind, placebo-controlled, single-dose, phase 3 trial in Russia
- Dmitry Lioznov,
- Irina Amosova,
- Savely A. Sheetikov,
- Ksenia V. Zornikova,
- Yana Serdyuk,
- Grigory A. Efimov,
- Mikhail Tsyferov,
- Mikhail Khmelevskii,
- Andrei Afanasiev,
- Nadezhda Khomyakova
x
- Published: March 8, 2023
- https://doi.org/10.1371/journal.pone.0278878